Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
about
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patternsPharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectivesEconomics of Team-based Care in Controlling Blood Pressure: A Community Guide Systematic ReviewInterventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007The potency of team-based care interventions for hypertension: a meta-analysis.Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.A primer for developing pharmacist-managed clinics in the outpatient setting.The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy.Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC)Incremental costs associated with physician and pharmacist collaboration to improve blood pressure controlAn update on evidence of clinical pharmacy services' impact on health-related quality of life.Impact of Pharmaceutical Care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), Brazil.Strategies for establishing policy, environmental, and systems-level interventions for managing high blood pressure and high cholesterol in health care settings: a qualitative case study.A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertensionCost-effectiveness of Wisconsin TEAM model for improving adherence and hypertension control in black patients.A collaborative cardiologist-pharmacist care model to improve hypertension management in patients with or at high risk for cardiovascular disease.The Team Education and Adherence Monitoring (TEAM) trial: pharmacy interventions to improve hypertension control in blacks.Pharmacy students' attitudes toward pharmaceutical care in QatarEvaluation of clinical pharmacy services in a hematology/oncology outpatient setting.Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.Pharmacist-physician collaboration for diabetes care: cardiovascular outcomes.Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population.Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-analysis.Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight.Role of the pharmacist in reducing healthcare costs: current insights.Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).Professional, structural and organisational interventions in primary care for reducing medication errors.Economic Evaluation of the Home Blood Pressure Telemonitoring and Pharmacist Case Management to Control Hypertension (Hyperlink) Trial
P2860
Q24234308-A738C43D-9AF1-46C2-9199-2847B7C4FAF7Q26773091-DEC361C0-6F12-4109-A3A6-48CA347DB25DQ28083249-FE26A628-F4B0-47B2-BF5D-D325135223E4Q33327179-3E31882B-21A8-4FC2-BF93-405C3C3E80C6Q33899620-F0C0AB5D-3D00-43FA-B7A3-C4F737810E8DQ34216882-CCDAA8DC-1E76-4618-92BF-D37AFF27230CQ34297241-99729E5D-4F25-440A-9576-B002A002D947Q35549767-1C4BF765-75D2-471B-B803-5489F3722F64Q35671360-02012A34-74D1-41D2-9105-6369AE73121EQ36171359-78FAA3AE-C7AB-4582-A93B-412E19D03D1AQ36533970-E1D5792F-7B9D-4A87-8B01-3475EA6D09D9Q36567150-8D8BE29B-7E13-4AAB-BF7C-C98ABF6BC718Q36663664-E8C37242-5BFC-4023-89CC-A309BAD45632Q36790686-119EB355-4219-4A61-9E7A-EF4B6D10E68FQ37000394-B7A039BB-56FE-44A9-BB3D-D3B9622C08BBQ37120964-56FB37D7-55DC-40F6-991A-4FEEE6F2405CQ37233368-EC7B7012-1222-422C-9FD1-BA58CA6C6EF8Q37454781-6339D31B-1737-4E78-9367-2CE9D1D8335CQ37609770-C75CEAEE-84A3-4B15-8C22-47E0ECB4A75AQ39764239-AD0F6B1A-2858-4FC1-9748-E31DBC5FD8E1Q43879797-28E7B7CA-09F2-436A-BC43-DB37373E8504Q44932292-8CF985FD-2218-4565-8D3B-BF33A8D3C261Q46054816-00EC517A-DA5B-4AF7-B853-F0D520840A1AQ46151910-BECE486D-665E-4330-A8C1-80AA34929E22Q47249315-ED999A14-2AB3-457B-A0AD-5D75C59A203FQ47320296-6528A5D6-5999-4357-B657-C95F5C05BD7AQ47721160-DEB241E9-102B-4B70-84F7-5EE6600D04AFQ47817797-D4F56695-2C62-42C2-B803-D43F587C0F6EQ47865717-6DDCD213-FD2F-4420-BE32-E226021CF096Q57487374-2211C68E-30E7-4E1D-A3DE-618DEC18C04E
P2860
Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
@en
Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
@nl
type
label
Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
@en
Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
@nl
prefLabel
Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
@en
Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
@nl
P2860
P1433
P1476
Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
@en
P2093
Nakahiro RK
Okamoto MP
P2860
P304
P356
10.1592/PHCO.21.17.1337.34424
P407
P577
2001-11-01T00:00:00Z